We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B Turnover 6.98%
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
-$38.8M
Cap. Flow
-$26.2M
Cap. Flow %
-2.45%
Top 10 Hldgs %
23.39%
Holding
296
New
5
Increased
79
Reduced
171
Closed
15
Avg Time Held
3.8 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
2.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.25%
2 Technology 12.7%
3 Healthcare 12.4%
4 Financials 12.28%
5 Consumer Staples 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZTS icon
276
Zoetis
ZTS
$32.4B
$207K 0.02%
+2,483
New +$196K
2018 Q1
0 quarters
DYSL
277
DELISTED
Dynasil Corporation of America
DYSL
$204K 0.02%
156,598
+5,297
+4% +$6.72K
2013 Q2
19 quarters
IMUX icon
278
Immunic
IMUX
$96.9M
$136K 0.01%
+50
New +$115K
2018 Q1
0 quarters
ICAD icon
279
DELISTED
iCAD Inc
ICAD
$46K ﹤0.01%
+15,000
New +$51.4K
2018 Q1
0 quarters
RGLS icon
280
DELISTED
Regulus Therapeutics
RGLS
$9K ﹤0.01%
100
+4
+4% +$535
2017 Q1
4 quarters
ATNM icon
281
Actinium Pharmaceuticals
ATNM
$33.3M
$8K ﹤0.01%
762
– –
2015 Q4
9 quarters
APA icon
282
APA Corp
APA
$16.5B
– –
-4,969
Closed -$210K –
BEN icon
283
Franklin Templeton
BEN
$15.9B
– –
-5,028
Closed -$218K –
BHF icon
284
Brighthouse Financial
BHF
$2.8B
– –
-4,116
Closed -$241K –
CHTR icon
285
Charter Communications
CHTR
$12.6B
– –
-605
Closed -$203K –
EW icon
286
Edwards Lifesciences
EW
$50.8B
– –
-5,808
Closed -$218K –
FBRX icon
287
DELISTED
Forte Biosciences
FBRX
– –
-44
Closed -$169K –
GLD icon
288
SPDR Gold Trust
GLD
$142B
– –
-2,967
Closed -$367K –
NOW icon
289
ServiceNow
NOW
$154B
– –
-17,215
Closed -$449K –
NVS icon
290
Novartis
NVS
$286B
– –
-2,834
Closed -$213K –
SCHG icon
291
Schwab US Large-Cap Growth ETF
SCHG
$64.1B
– –
-113,104
Closed -$1M –
SCHV icon
292
Schwab US Large-Cap Value ETF
SCHV
$15.5B
– –
-35,697
Closed -$651K –
SGOL icon
293
abrdn Physical Gold Shares ETF
SGOL
$6.97B
– –
-16,500
Closed -$208K –
PACW
294
DELISTED
PacWest Bancorp
PACW
– –
-8,271
Closed -$417K –
AGN
295
DELISTED
Allergan plc
AGN
– –
-1,253
Closed -$205K –
MFGP
296
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
– –
-6,807
Closed -$277K –

Similar funds

Dowling & Yahnke's Q1 2018 Portfolio in Review

As of Q1 2018, Dowling & Yahnke held 296 positions worth $1.07B, down 3.5% from $1.11B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Dowling & Yahnke's Q1 2018 filing shows 5 new, 79 increased, 171 reduced and 15 closed positions. Its largest new stake was Schwab Fundamental US Broad Market Index ETF: 19,500 shares worth $235K. The largest sale was Global X S&P 500 Catholic Values ETF, an estimated $2.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q1 2018 buy was Schwab Fundamental US Broad Market Index ETF: 19,500 shares worth $235K.
  • Dowling & Yahnke added most to Realty Income in Q1 2018, an estimated $566K increase.
  • Dowling & Yahnke's biggest Q1 2018 reduction was Global X S&P 500 Catholic Values ETF, cutting an estimated $2.13M.
  • Dowling & Yahnke fully exited Schwab US Large-Cap Growth ETF in Q1 2018, selling an estimated $1M.
  • Dowling & Yahnke's ten largest holdings make up 23% of its $1.07B portfolio in Q1 2018.
  • Dowling & Yahnke opened 5 new positions and closed 15 in Q1 2018.
  • Dowling & Yahnke's portfolio value fell 3.5% quarter-over-quarter to $1.07B.

Based on Dowling & Yahnke's 13F filing for Q1 2018, filed 1 May 2018.